IM Cannabis Corp. current report, Q3 FY2022

IM Cannabis Corp. Form 6-K Summary

Business Context and Reporting Period

IM Cannabis Corp., an Israeli-domiciled foreign private issuer, filed this Form 6-K on August 8, 2022, for the month of August 2022. The filing is submitted under Form 40-F and identifies Exhibit 99.1 as a Form 7 Monthly Progress Report dated August 8, 2022. The provided filing text does not include the contents of that exhibit.

Financial and Operating Metrics

The filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, operating results, or other financial metrics.

Material Changes Versus the Prior Comparable Period

No comparative financial or operating information is included in the provided filing text. Accordingly, material changes versus the prior comparable period cannot be determined.

Guidance, Outlook, Risks, and Unusual Items

The filing text does not include management guidance, outlook commentary, risk disclosures, contingencies, or descriptions of unusual items. Any such information may be contained in Exhibit 99.1, which is referenced but not provided.

Key Facts for Investors to Verify

  • Obtain and review Exhibit 99.1, the Form 7 Monthly Progress Report dated August 8, 2022.
  • Verify whether the exhibit contains financial results, operating updates, material events, or regulatory disclosures not included in the Form 6-K cover filing.
  • Confirm any reported changes in liquidity, debt, cannabis operations, guidance, or material risks from the complete exhibit.